NIH-funded research Career grant

How diabetes affects infections caused by Group B Streptococcus in wounds

Official title: The Diabetic Wound Environment Shapes Group B Streptococcal Pathogenesis

Funded at University of Colorado Denver · NIH-11115717 · Data updated 2026-11-12

This study is looking at how the special conditions of diabetic wounds affect a common bacteria called Group B Streptococcus, which can cause infections, and it aims to help improve treatments for people with diabetes who have these wounds.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startJune 13, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$100,000
NIH project number5K99AI180373-02
Project IDNIH-11115717 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with diabetes who have developed chronic wounds or infections.

Less likely to help

Patients without diabetes or those who do not have chronic wounds may not benefit from this research.

What this research studies

This research investigates how the unique environment of diabetic wounds influences the behavior of Group B Streptococcus (GBS), a common bacterial pathogen in these infections. By studying mouse models, the research aims to understand how factors like immune response and high blood sugar levels contribute to GBS infections in diabetic patients. The project will explore the role of neutrophils, a type of immune cell, and how their altered function impacts the severity of infections. The findings could lead to better treatment strategies for diabetic wound infections.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for diabetic patients suffering from chronic wounds and reduce the risk of severe complications like amputations.

How similar studies have gone: Previous research has shown that understanding the specific interactions between bacteria and the diabetic wound environment can lead to significant advancements in treatment, indicating that this approach has potential for success.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Keogh, Rebecca — University of Colorado Denver
  • Study coordinator: Keogh, Rebecca

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.